Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 

Drawing inspiration from nature, synthetic biology offers exciting opportunities to transform the future of medicine.

Neurological disorders often have sex biases, and these differences could be due to altered protein expression in the brain.

With deep learning methods revolutionizing life sciences, researchers bet on de novo proteins and cell mapping models to deliver customized precision medicines.

The common fluorescent marker GFP traveled a long road to take its popular place in molecular biology today.

Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.

S.A. Rosenberg, P. Aebersold, K. Cornetta, A. Kasid, et al., "Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction," New England Journal of Medicine, 323:570-78, 1990. Steven A. Rosenberg (National Cancer Institute, Bethesda, Md.): "The practice of medicine in the future may well be transformed as we learn to treat disease not by surgery, radiation, or drugs, but rather by genetic alteration

Blocking an abnormally active signaling pathway in skeletal stem and progenitor cells alleviates bone mass decline in middle-aged mice. 

A new platform for screening astrocyte reactivity helps researchers uncover potential therapeutic interventions to treat neurodegenerative conditions.